SynthesisFrontiers in pharmacology2019

The Differences in the Safety and Tolerability of Immune Checkpoint Inhibitors as Treatment for Non-Small Cell Lung Cancer and Melanoma: Network Meta-Analysis and Systematic Review.

Qing-Qing Chai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.